From: The effects of the COVID-19 pandemic on patients with lysosomal storage disorders in Israel
Questionnaire data | No. ( %) |
---|---|
Total | 48 (100) |
Males (%) | 29 (60) |
No. (%) of patients treated with ERT* or other parenteral | 28 (58.3) |
No.(%) of patients that missed ERT or parenteral treatments during COVID-19 pandemic | 7 (25) |
No. (%) of patients that were under the age 18Â years during COVId-19 pandemic | 46 (95) |
No. (%) of patients reporting mood deterioration during COVID-19 pandemic | 7 (14.6) |
No. (%) of patients reporting increased aggressiveness during COVID-19 pandemic | 7 (14.6) |
No. (%) of patients reporting cognitive function decline during COVID-19 pandemic | 8 (16.7) |
No. (%) of patients reporting motor function decline during COVID-19 pandemic | 11 (23.9) |